Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Pharmacoepidemiology and Drug Safety|March 9, 2019
Personalized benefit-risk assessments combining clinical trial and real-world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapyCathy Anne Pinto, Tommi Tervonen, Kevin Marsh, et al.
BMJ (Clinical Research Ed.)|August 13, 2009
Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug AdministrationMarc Stone, Thomas Laughren, M Lisa Jones, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Patient Engagement at a Tipping Point-The Need for Cultural Change Across Patient, Sponsor, and Regulator Stakeholders: Insights From the DIA Conference, "Patient Engagement in Benefit Risk Assessment Throughout the Life Cycle of Medical Products"Meredith Y Smith, Tarek A Hammad, Marilyn Metcalf, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 20, 2021
The utility of geriatric nutritional risk index to predict outcomes in chronic limb-threatening ischemiaJun Li, Shilpkumar Arora, Kuniyasu Ikeoka, et al.
Pharmacoepidemiology and Drug Safety|June 5, 2013
Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRDAndrea V Margulis, Adel Abou-Ali, Marian M Strazzeri, et al.
BMJ (Clinical Research Ed.)|August 2, 2022
Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysisMarc B Stone, Zimri S Yaseen, Brian J Miller, et al.
Pharmacoepidemiology and Drug Safety|July 28, 2010
Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008Ann W McMahon, Robert G Pratt, Tarek A Hammad, et al.
The Journal of Invasive Cardiology|February 11, 2021
Prospective Experience of Pulmonary Embolism Management and OutcomesMatthew J Lacey, Tarek A Hammad, Melanie Parikh, et al.
Vascular Medicine (London, England)|February 22, 2019
SDF-1 plasmid treatment for patients with peripheral artery disease (STOP-PAD): Randomized, double-blind, placebo-controlled clinical trialMehdi H Shishehbor, John Rundback, Matthew Bunte, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|May 19, 2020
Stromal Cell-Derived Factor-1 Plasmid Treatment for Patients With Peripheral Artery Disease (STOP-PAD) Trial: Six-Month ResultsTarek A Hammad, John Rundback, Matthew Bunte, et al.
Pageof 8